loader
Please Wait
Applying Filters...

Looking for Danofloxacin Mesylate? Find Danofloxacin Mesylate based excipient solutions to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 692Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Boai NKY Pharmaceuticals Ltd

02 1Actylis

03 1Ashland

04 38BASF

05 2CD Formulation

06 2Gangwal Chemicals

07 1Microlex e.U

08 3Novo Excipients

09 1Pharmatrans-Sanaq

10 2Pluviaendo

11 2Shanghai Welltone Material Technology Co., Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBoai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Grade : Parenteral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBoai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Ingredient(s) : 2-Pyrrolidone

Dosage Form : Injectable / Parenteral

Category : Solubilizers

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBoai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Grade : Oral (Pharma Grade)

Brand Name : KoVidone® K25

Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

Grade : Oral (Pharma Grade)

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBoai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Ingredient(s) : Polyvinylpyrrolidone

Dosage Form : Capsule, Tablet

Category : Fillers, Diluents & Binders

Brand : KOVIDONE® K25

Applications : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

Grade : Oral (Pharma Grade)

arrow

04

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Brand : KOLLIDON SR

Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specs : Not Available

Grade : Not Available

arrow
blank

07

arrow
AGGSpend
Not Confirmed
blank

09

arrow
AGGSpend
Not Confirmed

11

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed
blank

17

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed
blank

19

arrow
AGGSpend
Not Confirmed

20

arrow
AGGSpend
Not Confirmed

21

arrow
AGGSpend
Not Confirmed